Search

Displaying results 8851 - 8860 of 10000 in total
  1. Drug

    Ulocuplumab

    go.drugbank.com/drugs/DB12018
    Investigational

    Ulocuplumab is under investigation in Solid Tumor.

  2. Drug

    Iguratimod

    go.drugbank.com/drugs/DB12233
    Investigational

    Iguratimod is under investigation in Rheumatoid Arthritis.

  3. Drug

    Piribedil

    go.drugbank.com/drugs/DB12478
    Investigational

    Piribedil has been investigated in Parkinson's Disease.

  4. Drug

    Aleplasinin

    go.drugbank.com/drugs/DB12635
    Investigational

    Aleplasinin has been investigated in Alzheimer Disease.

  5. Drug

    AKI-001

    go.drugbank.com/drugs/DB07266
    Experimental

    AKI-001 is an aurora kinase inhibitor.

  6. Drug

    BGB-DXP593

    go.drugbank.com/drugs/DB16357
    Investigational

    [L27401] It is currently being investigated against COVID-19 in the clinical trial NCT04551898 (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants

  7. Drug

    Tasurgratinib

    go.drugbank.com/drugs/DB21222
    Investigational

    The usage of the INN stem '-gratinib' in the name indicates that Tasurgratinib is a fibroblast growth factor receptor (FGFR) inhibitor. … Tasurgratinib is under investigation in clinical trial NCT04962867 (NCCH2006/MK010 Trial (FORTUNE Trial)). Tasurgratinib has a monoisotopic molecular weight of 587.27 Da.

    Synonyms: E 7090
  8. Drug

    Retosiban

    go.drugbank.com/drugs/DB11818
    Investigational

    Retosiban has been used in trials studying the treatment of Premature Labor and Obstetric Labour, Premature.

  9. Drug

    AMT-080

    go.drugbank.com/drugs/DB17846
    Experimental

    AMT-080 is an investigational gene therapy being investigated for the treatment of Duchenne muscular dystrophy.

  10. Drug

    CTX130

    go.drugbank.com/drugs/DB18627
    Investigational

    CTX130 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD70 antigen.